MICROLAX SORBITOL CITRATE and LAURILSULFOACETATE DE SODIUM, rectal solution in a single-dose container 12 single-dose containers of 6.45 g
Brand page: Microlax (sodium citrate + sodium laurylsulfoacetate + sorbitol) — all forms and strengths in France
Active ingredients: Sodium citrate, Sodium lauryl sulfoacetate, SORBITOL À 70 POUR CENT CRISTALLISABLE
Commercialized according to BDPM
Solution12 single-dose containers of 6.45 grectale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MICROLAX SORBITOL CITRATE ET LAURILSULFOACETATE DE SODIUM, solution rectale en récipient unidose
- Pharmaceutical form
- solution
- Route of administration
- rectale
- Presentation description
- 12 récipient(s) unidose(s) polyéthylène de 6,45 g avec canule polyéthylène
- Marketing authorisation holder
- KENVUE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 Sept 2001
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67904304CIP73496881CIP133400934968815Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CITRATE DE SODIUMsolution | 0,4500 g · un récipient unidose | SA |
| SODIUM (LAURILSULFOACÉTATE DE)solution | 0,0645 g de laurilsulfoacétate de sodium à 70 % · un récipient unidose | SA |
| SORBITOL À 70 POUR CENT CRISTALLISABLEsolution | 4,4650 g · un récipient unidose | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.